Monday, December 11, 2017
 
 
News: Page (1) of 1 - 10/19/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Biotech company Amgen laying off about 380 in R&D
Biotech company Amgen laying off about 380 in restructuring of its research & development
By The Associated Press

THOUSAND OAKS, Calif. (AP) ' Amgen Inc. is laying off about 380 employees in research and development as it restructures its R&D operations.

The biotech company, based in Thousand Oaks, Calif., says the layoffs are targeted to enable the company to better allocate its research and development resources.

Company spokeswoman Christine Regan says the affected employees were notified Wednesday. They work at several Amgen sites, in both the U.S. and the United Kingdom.



Amgen has a total of about 17,600 employees worldwide, including roughly 6,700 in research and development.

In a statement, Amgen says it has experimental drugs moving into expensive, later-stage patient testing so it has to shift some R&D resources so it can invest in the testing needed to get the drugs approved.


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines